ENA Respiratory Publishes Review of Development of Novel Intranasal Antiviral Host Defense Immune Enhancer INNA-051 in Antiviral Research
ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defense immune enhancers to minimize the impact of respiratory viral infections in at-risk populations, announces ...
ena8d
House Appoints Human Rights Chief Commissioner
The House of People's Representatives has appointed Berhanu Adelo as Chief Commissioner of the Ethiopian Human Rights ...
Yahoo Finance8d
Enalare Therapeutics Receives Second Component of a National Institutes of Health (NIH) Grant Award to Fund the Next Human Study of ENA-001
We believe that ENA-001's differentiated approach to stimulating ... in part with federal funds from the Department of Health and Human Services, Administration for Strategic Preparedness and ...
PharmiWeb8d
Enalare Therapeutics Receives Second Component of…
Funding from the NIH's National Institute on Drug Abuse (NIDA) will Support Development of ENA-001, an Agnostic Respiratory Stimulant, for Community Drug Overdose and as a Medical ...